NCT03436368Active, not recruiting
Continuous Spinal Anesthesia in Renal Transplantation
Continuous Spinal Anesthesia for Renal Transplant Recipients
Source: ClinicalTrials.gov · Last updated 12 Jan 2026
Brief summary (registry, in English)
Renal transplantation is now recognized as a treatment of choice for patients with end-stage renal disease. An adequate anesthetic technique should achieve hemodynamic stability and enhance perfusion of the transplanted kidney. The aim of this study is to assess the use \& effects of continuous spinal anesthesia for kidney transplantation recipients, compared with balanced general anesthesia.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 12 Feb 2018
- Start date
- 20 Feb 2018
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Nazmy Edward Seif
- Diseases
- Chronic kidney disease
- NCT number
- NCT03436368
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 20 Feb 2018 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any condition contra-indicating regional anesthesia
- Allergic to any of the drugs used during the procedure
Other
- Coagulopathy
Who the study is looking for
- ASA class III or IV
- End-stage renal disease
- Renal transplantation candidate patients
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kasr Al-Ainy Hospital, Cairo University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.